1111556-37-6 Usage
General Description
Takinib, also known as AS-703026, is an experimental chemical compound being studied for its potential as a selective inhibitor of the enzyme p70S6 kinase (p70S6K). This enzyme plays a role in regulating cell growth and proliferation and has been implicated in various diseases, including cancer and metabolic disorders. Takinib has shown promising results in preclinical studies, demonstrating the ability to inhibit p70S6K activity and reduce tumor growth in animal models. It is being investigated as a potential therapeutic option for the treatment of cancer and other conditions associated with dysregulated cell growth and proliferation. Further research is needed to fully understand the potential benefits and risks of using Takinib in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 1111556-37-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,1,5,5 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1111556-37:
(9*1)+(8*1)+(7*1)+(6*1)+(5*5)+(4*5)+(3*6)+(2*3)+(1*7)=106
106 % 10 = 6
So 1111556-37-6 is a valid CAS Registry Number.
1111556-37-6Relevant articles and documents
NOVEL INHIBITORS OF TRANSFORMING GROWTH FACTOR KINASE AND METHODS OF USE THEREOF
-
Paragraph 0226; 0228; 0230; 0231, (2018/04/26)
The present invention provides novel inhibitors of TAK1 and methods of using such compounds to treat various diseases.
